1-Butyl-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 1g

cis-4-Hydroxy-D-proline>98.0%(HPLC)(T)1g

5,5-Bis(bromomethyl)-2,2-dimethyl-1,3-dioxane, 95.0%, 5g

1,2-Dimethyl-1H-indole-3-carbonitrile, 95.0%, 1g

3,5-Difluorobenzaldehyde, 98.0%, 25g

9,9'-Spirobi[fluorene], 95.0%, 100g

Ethyl 5,6-dibromonicotinate, 97%, 250mg

4-(3-IODO-1H-PYRAZOL-4-YL)PYRIMIDINE, 95.0%, 250mg

(3aS,3a'S,8aR,8a'R)-2,2'-(Cyclopentane-1,1-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole), 97.0%, 250mg

Lenalidomide-C4-NH2 (hydrochloride), 100mg

2-(6-Chloro-4-trifluoromethyl-pyridin-2-ylsulfanyl)-N-ethyl-acetamide, 95.0%, 100mg

Microtiter plates cellGrade F-bottom (transparent) sterile, white 50 pcs

5-Bromo-3-methyl-2-(trifluoromethyl)pyridine, 95%, 5g